Ebola Viral Infections Market Treatment, Analysis and Outlook and Pipeline Review, H1 2016: Radiant Insights

Summary
Global Markets Direct's, 'Ebola Viral Infections - Pipeline Review, H1 2016', provides an overview of the Ebola Viral Infections pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Ebola Viral Infections, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Ebola Viral Infections and features dormant and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Request Sample Copy of This Report @ http://www.radiantinsights.com/research/ebola-viral-infections-pipeline-review-h1-2016/request-sample

Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Market Size, Causes, Outlook, Overview and Pipeline Review, H1 2016

Summary
Global Markets Direct's, 'Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Pipeline Review, H1 2016', provides an overview of the Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) and features dormant and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Request Sample Copy of This Report @ http://www.radiantinsights.com/research/chronic-myelocytic-leukemia-cml-chronic-myeloid-leukemia-pipeline-review-h1-2016/request-sample

About Us:
Radiant Insights Inc. is a platform for companies looking to meet their market research and business intelligence requirements. We assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process. We have a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, our experienced research coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research solutions.

Contact Details:
Michelle Thoras
Corporate Sales Specialist, USA
Radiant Insights, Inc
28 2nd Street,
Suite 3036 San Francisco,
CA 94105 United States
Phone: 1-415-349-0054
Toll Free: 1-888-202-9519
Website: http://www.radiantinsights.com/
Email: sales@radiantinsights.com
Visit our Blog: http://chemicalsandmaterialsri.blogspot.com/

Cervical Cancer Market Causes, Analysis and Outlook, Overview and Pipeline Review, H1 2016

Summary
Global Markets Direct's, 'Cervical Cancer - Pipeline Review, H1 2016', provides an overview of the Cervical Cancer pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Cervical Cancer, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Cervical Cancer and features dormant and discontinued projects.

For More Information, Visit @ http://www.radiantinsights.com/research/cervical-cancer-pipeline-review-h1-2016

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Request Sample Copy of This Report @ http://www.radiantinsights.com/research/cervical-cancer-pipeline-review-h1-2016/request-sample

Global Chronic Lymphocytic Leukemia Market is Expected to Reach at a CAGR of 19.16% by 2020

About the Chronic Lymphocytic Leukemia (CLL) Therapeutics Market
Cancer that starts from the hematopoietic stem cells of the bone-marrow is referred to as leukemia. Leukemia can be chronic or acute depending on the maturity of the cells. In addition, based on the bone marrow cells from which the cancer starts, leukemia can be categorized as lymphocytic or myeloid. Hence, leukemia can be broadly classified into four types:
-Acute myeloid (or myelogenous) leukemia (AML)
-Chronic myeloid (or myelogenous) leukemia (CML)
-Acute lymphocytic (or lymphoblastic) leukemia (ALL)
-CLL

Technavio's analysts forecast the global CLL therapeutics market to grow at a CAGR of 19.16% during the period 2016-2020.

Covered in this report
The report covers the present scenario and the growth prospects of the global CLL therapeutics market for 2016-2020. To calculate the market size, the report considers revenue generated from the sales of branded and generic drugs used to treat and prevent CLL. The report also considers the revenues to be generated from the sales of drugs that are expected to be launched into the market along with the decline in revenues from the genericization of the marketed drugs during the forecast period.

The market is divided into the following segments based on geography:
-Americas
-APAC
-EMEA

Technavio's report, Global Chronic Lymphocytic Leukemia (CLL) Therapeutics Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the Key vendorsoperating in this market.

Request Sample Copy of This Report @ http://www.radiantinsights.com/research/global-chronic-lymphocytic-leukemia-market-2016-2020/request-sample 

Global Breast Pump Market to Grow at a CAGR of 10.16% by 2020: Radiant Insights

About the Breast Pump Market
Breast pumps are devices used to suction milk from the breasts of lactating mothers and store it in a container to provide a continuous supply of breast milk for feeding their infants as and when required. For instance, when the mothers are not able to feed directly or are away for work, the stored milk can be fed to the infant by the caretakers. Breast pumps assist in triggering the milk ejection response from lactating mothers by creating a seal around the nipple and applying and releasing pressure.

Technavio's analysts forecast the global breast pump market to grow at a CAGR of 10.16% during the period 2016-2020.

Click Here For Complete Report @ http://www.radiantinsights.com/research/global-breast-pump-market-2016-2020

Covered in this report
The report covers the present scenario and the growth prospects of the global breast pump market for 2016-2020. To calculate the market size, we use the revenue generated from the sales of manual, electric, and battery-powered breast pumps.

The market is divided into the following segments based on geography:
-Americas
-APAC
-EMEA

Request Sample Copy of This Report @ http://www.radiantinsights.com/research/global-breast-pump-market-2016-2020/request-sample

Global and China Dental Chair Market Share, Global Insights and Forecasts to 2020

This report studies Dental Chair Industry in Global and China market, focuses on price, sales, revenue of each type in global China. This report also focuses on the sales (consumption), production, import and export of Dental Chair Industry in North America, Japan, Europe, India, Southeast Asia and China, forecast to 2020, from 2015.

Split by product types, with sales, revenue, market share and price of each type, as well as the types and each type price of key manufacturers, through interviewing key manufacturers, in 2015 and 2016, covering
Power-driven
Pneumatic

Browse Full Report with TOC @ http://www.radiantinsights.com/research/global-and-china-dental-chair-industry-research-report-to-2020

Split by manufacturers, this report focuses on the sales, price of each type, average price of Dental Chair Industry, revenue and market share, for each manufacturer in 2015 and 2016. Top players, covering
Sirona Dental Systems Inc.
A-Dec Inc
Danaher Corporation
Planmeca
Midmark Corporation
Morita
Shinhung
Castellini
DentalEZ
GC Corporation
Yoshida
SDS Dental, Inc.
Belmont
Sinol
Join Champ
SHP
Fimet
Suntem
Foshan Anle
Hongke Medical
Hiwon
Detes
HB Dental
Ajax
The Flight

Global and China Antihypertensive Drugs Market is Projected to Grow at 1.2%, to Reach USD 30 Billion by 2020

The global antihypertensive drugs market is estimated to grow at 1.2% during the forecast period, to reach USD 30 billion. Hypertension is a lifelong disease, which means that a patient may require to take medications every day for the rest of his/her life. Thus, the demand for anti-hypertensive dugs is sustainable and will increase with the rapidly increasing aging population.

This report studies Antihypertensive Drugs in Global and China market, focuses on price, sales, revenue of each type in global China. This report also focuses on the sales (consumption), production, import and export of Antihypertensive Drugs in North America, Japan, Europe, India, Southeast Asia and China, forecast to 2020, from 2015.

Split by product types, with sales, revenue, market share and price of each type, as well as the types and each type price of key manufacturers, through interviewing key manufacturers, in 2015 and 2016, covering
Diuretics
Calcium channel blockers (CCB)
ACE inhibitors (ACE-I)
Angiotensin II receptor antagonists (ARB)
Adrenergic receptor antagonists
Vasodilators
Benzodiazepines
Renin Inhibitors
Aldosterone receptor antagonists
Alpha-2 adrenergic receptor agonists